To B or Not to B, That Is the Question: Is It Time to Replace Colistin With Polymyxin B?-Reference-Cited by-同舟云学术

To B or Not to B, That Is the Question: Is It Time to Replace Colistin With Polymyxin B?

Published:2014-10-24 Issue:1 Volume:35 Page:17-21
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Kassamali Zahra¹,Danziger Larry²

Affiliation:

1. Department of Pharmaceutical Services; University of California Los Angeles; Los Angeles California

2. Department of Pharmacy Practice; University of Illinois; Chicago Illinois

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1510/fullpdf

Reference36 articles.

1. World Health Organization Antimicrobial resistance: global report on surveillance 2014 http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf

2. Polymyxins revisited;Landman;Clin Microbiol Rev,2008

3. Polymyxins: wisdom does not always come with age;Kassamali;Clin Infect Dis,2013

4. Colistin and Polymyxin B: peas in a pod, or chalk and cheese?;Nation;Clin Infect Dis,2014

5. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients;Garonzik;Antimicrob Agents Chemother,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling neurotoxicity discrepancies: comparative in vitro and In vivo analysis of colistin and polymyxin B and the underlying mechanisms;2023-09-12

2. Intrathecal drug delivery of antibiotics;Cerebrospinal Fluid and Subarachnoid Space;2023

3. Synergy of a virulent phage (φAB182) with antibiotics leading to successful elimination of biofilms formed by MDR Acinetobacter baumannii;Canadian Journal of Microbiology;2022-12-01

4. Manual Reading of Sensititre Broth Microdilution System Panels Improves Accuracy of Susceptibility Reporting for Polymyxin Antibiotics;Journal of Clinical Microbiology;2021-08-18

5. Optimal Empiric Polymyxin B Treatment of Patients Infected with Gram-Negative Organisms Detected Using a Blood Antimicrobial Surveillance Network in China;Drug Design, Development and Therapy;2021-06